The Latest Regenerative Medicine Articles from Streetwise Reports


Regenerative Medicine Firm Reports Positive Chronic Lower Back Pain Trial Results

Research Report
  ()
New study data and next steps for Mesoblast's MPC-06-ID are presented in a Dawson James Securities report. read more >

Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy

Research Report
  ()
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report. read more >
Showing Results: 1 to 2 of 2

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe